Zeitschriftenartikel zum Thema „XP“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "XP" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Cowham, R. "To XP or not to XP?" ITNOW 47, no. 2 (2005): 16. http://dx.doi.org/10.1093/itnow/bwi030.
Der volle Inhalt der QuelleFischer, R., M. Uhl, and H. Vonach. "Nb93(n,xp),Agnat(n,xp), andInnat(n,xp) reactions at 14.1 MeV." Physical Review C 37, no. 2 (1988): 578–86. http://dx.doi.org/10.1103/physrevc.37.578.
Der volle Inhalt der QuelleSonia, Archana Singhal, and Hema Banati. "FISA-XP." ACM SIGSOFT Software Engineering Notes 39, no. 3 (2014): 1–14. http://dx.doi.org/10.1145/2597716.2597728.
Der volle Inhalt der QuelleLitts, Thom, and Jeff Kopaska. "RIP XP." Fisheries 39, no. 4 (2014): 151. http://dx.doi.org/10.1080/03632415.2014.893871.
Der volle Inhalt der QuelleIvorra, Wilfrid. "Sur les équations xp+2βyp= z2et xp+2βyp= 2z2". Acta Arithmetica 108, № 4 (2003): 327–38. http://dx.doi.org/10.4064/aa108-4-3.
Der volle Inhalt der QuelleLee, Jeeyun, Do Hoon Lim, Sung Kim, et al. "Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial." Journal of Clinical Oncology 30, no. 3 (2012): 268–73. http://dx.doi.org/10.1200/jco.2011.39.1953.
Der volle Inhalt der QuelleFassihi, Hiva, Mieran Sethi, Heather Fawcett, et al. "Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect." Proceedings of the National Academy of Sciences 113, no. 9 (2016): E1236—E1245. http://dx.doi.org/10.1073/pnas.1519444113.
Der volle Inhalt der QuelleAbid, Kalthoum, Jihene Bettaieb, Faouzi El Mezni, and Hamouda Boussen. "Proinflammatory cytokines in xeroderma pigmentosum (XP) and non-XP cancer patients—a pilot study." Exploration of Immunology 4, no. 4 (2024): 557–67. http://dx.doi.org/10.37349/ei.2024.00159.
Der volle Inhalt der QuelleMaxmen, Amy. "XP mutant power!" Journal of Experimental Medicine 206, no. 13 (2009): 2856. http://dx.doi.org/10.1084/jem.20613iti2.
Der volle Inhalt der QuelleMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi та ін. "Общие аспекты пигментной ксеродермии: обзор". Núcleo do Conhecimento 11, № 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/ru/70626.
Der volle Inhalt der QuelleKunwar, Sundar. "Enabling and Limiting factors in eXtreme Programming (XP) with Evaluation Framework." SCITECH Nepal 14, no. 1 (2019): 50–62. http://dx.doi.org/10.3126/scitech.v14i1.25534.
Der volle Inhalt der QuelleRapićOtrin, Vesna, Isao Kuraoka, Tiziana Nardo, et al. "Relationship of the Xeroderma Pigmentosum Group E DNA Repair Defect to the Chromatin and DNA Binding Proteins UV-DDB and Replication Protein A." Molecular and Cellular Biology 18, no. 6 (1998): 3182–90. http://dx.doi.org/10.1128/mcb.18.6.3182.
Der volle Inhalt der QuelleMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Allgemeine Aspekte von Xeroderma pigmentosum: Eine Übersicht." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/gesundheit/aspekte-von-xeroderma.
Der volle Inhalt der QuelleStanojevic, Jelena. "On estimation of high quantiles for certain classes of distributions." Yugoslav Journal of Operations Research 25, no. 2 (2015): 299–312. http://dx.doi.org/10.2298/yjor130606013s.
Der volle Inhalt der QuelleMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspectos gerais do xeroderma pigmentoso: Uma revisão." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/saude/aspectos-gerais-do-xeroderma.
Der volle Inhalt der QuelleMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspetti generali dello xeroderma pigmentoso: una revisione." Núcleo do Conhecimento 11, no. 03 (2022): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/salute/generali-dello-xeroderma.
Der volle Inhalt der QuelleMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "General aspects of xeroderma pigmentosum: A review." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/xeroderma-pigmentosum.
Der volle Inhalt der QuelleKim, Jinsu, and Wonho Lee. "Flood Inundation Analysis in Urban Area Using XP-SWMM." Journal of the Korean Geoenvironmental Society 16, no. 1 (2015): 29–36. http://dx.doi.org/10.14481/jkges.2015.16.1.29.
Der volle Inhalt der QuelleSuman, AHM Khairul Imam, Khadija Begum, Kaniz Rahman, et al. "Association of Xanthelasma palpebrarum (XP) with cardiovascular disease (CVD) risk factors." Asian Journal of Medical and Biological Research 5, no. 4 (2020): 324–29. http://dx.doi.org/10.3329/ajmbr.v5i4.45271.
Der volle Inhalt der QuelleMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspectos generales del xeroderma pigmentoso: una revisión." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/salud/xeroderma-pigmentoso.
Der volle Inhalt der QuelleVaz-Garcia, Eduarda Santiago, Victor Talarico Leal Vieira, Natasha Pereira da Silva Ferreira Petitet, et al. "Mechanical Properties of Anatomic Finishing Files: XP-Endo Finisher and XP-Clean." Brazilian Dental Journal 29, no. 2 (2018): 208–13. http://dx.doi.org/10.1590/0103-6440201801903.
Der volle Inhalt der QuelleGambichler, Thilo, Julia Hyun, Frank Oellig, Jürgen C. Becker, and Alexander Kreuter. "Immuncheckpoint‐Inhibitoren bei Kindern mit Xeroderma pigmentosum und fortgeschrittenem kutanen Plattenepithelkarzinom: Fallvorstellung und kurzer Überblick." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 23, no. 3 (2025): 303–10. https://doi.org/10.1111/ddg.15648_g.
Der volle Inhalt der QuelleWebster, Mark A., Benjamin J. Brown, and Stephen D. Bartlett. "The XP Stabiliser Formalism: a Generalisation of the Pauli Stabiliser Formalism with Arbitrary Phases." Quantum 6 (September 22, 2022): 815. http://dx.doi.org/10.22331/q-2022-09-22-815.
Der volle Inhalt der QuelleKim, Young Geun, Jae Wook Oh, Keun Cheol Lee, and Sung Ho Yoon. "Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum." Archives of Craniofacial Surgery 23, no. 2 (2022): 71–76. http://dx.doi.org/10.7181/acfs.2022.00185.
Der volle Inhalt der QuellePhillies, George David Joseph. "Simulational Tests of the Rouse Model." Polymers 15, no. 12 (2023): 2615. http://dx.doi.org/10.3390/polym15122615.
Der volle Inhalt der QuellePrice, Vera H. "Trichothiodystrophy: Current Concepts." Journal of Cutaneous Medicine and Surgery 1, no. 1 (1996): 45–49. http://dx.doi.org/10.1177/120347549600100113.
Der volle Inhalt der QuelleMiao, Junjie, Changchun Chai, Wei Zhang, Yanxing Song, and Yintang Yang. "First-Principles Study on Structural, Mechanical, Anisotropic, Electronic and Thermal Properties of III-Phosphides: XP (X = Al, Ga, or In) in the P6422 Phase." Materials 13, no. 3 (2020): 686. http://dx.doi.org/10.3390/ma13030686.
Der volle Inhalt der QuelleLee, J., W. Kang, D. Lim, et al. "Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis." Journal of Clinical Oncology 27, no. 15_suppl (2009): 4537. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.4537.
Der volle Inhalt der QuelleFernández-Sánchez, Javier. "Against a clausal ellipsis account of all stripping strings in Spanish." Poznan Studies in Contemporary Linguistics 55, no. 1 (2018): 53–87. http://dx.doi.org/10.1515/psicl-2019-0003.
Der volle Inhalt der QuelleReifer, D. J. "XP and the CMM." IEEE Software 20, no. 3 (2003): 14–15. http://dx.doi.org/10.1109/ms.2003.1196314.
Der volle Inhalt der QuelleTorre, Alberto C. de la. "The ubiquitous XP commutator." European Journal of Physics 27, no. 2 (2006): 225–30. http://dx.doi.org/10.1088/0143-0807/27/2/005.
Der volle Inhalt der QuelleFraser, Steven, and Giancarlo Succi. "XP requirement negotiation workshop." ACM SIGAPP Applied Computing Review 10, no. 1 (2002): 26–31. http://dx.doi.org/10.1145/568235.568239.
Der volle Inhalt der QuelleSchwarz, Diemo, and Etienne Brunet. "theconcatenator: Placard XP edit." Leonardo Music Journal 18 (December 2008): 89–90. http://dx.doi.org/10.1162/lmj.2008.18.89b.
Der volle Inhalt der QuelleJ.-M.M. "XP Centaur en majesté." Revue Francophone des Laboratoires 2007, no. 388 (2007): 10. http://dx.doi.org/10.1016/s1773-035x(07)80003-7.
Der volle Inhalt der QuelleGengler, Barbara. "XP a National Threat?" Network Security 2001, no. 11 (2001): 5. http://dx.doi.org/10.1016/s1353-4858(01)01111-4.
Der volle Inhalt der QuelleSundar, Kunwar. "Extreme Programming (XP) Simplified." European Journal of Advances in Engineering and Technology 5, no. 3 (2018): 198–206. https://doi.org/10.5281/zenodo.10702437.
Der volle Inhalt der QuelleBeroual, Nabil, and Ahmed Bendjeddou. "On a Predator–Prey System with Holling Functional Response: xp/(a + xp)." National Academy Science Letters 39, no. 1 (2015): 43–46. http://dx.doi.org/10.1007/s40009-015-0400-6.
Der volle Inhalt der QuelleSarasin, Alain. "The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies." Cancers 15, no. 10 (2023): 2706. http://dx.doi.org/10.3390/cancers15102706.
Der volle Inhalt der QuelleMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspects généraux de Xeroderma pigmentosum: un examen." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/sante/generaux-de-xeroderma.
Der volle Inhalt der QuelleRana, MS, MM Rahman, UK Rima, and NS Juyena. "General anaesthesia of indigenous pigs in Bangladesh." Bangladesh Veterinarian 30, no. 2 (2014): 46–53. http://dx.doi.org/10.3329/bvet.v30i2.18254.
Der volle Inhalt der QuelleKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428-3432.1986.
Der volle Inhalt der QuelleKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428.
Der volle Inhalt der QuelleMartens, M. C., L. Boeckmann, and S. Emmert. "Genetisch bedingte Hauterkrankungen – Xeroderma pigmentosum und das CEDNIK-Syndrom." Aktuelle Dermatologie 46, no. 08/09 (2020): 375–78. http://dx.doi.org/10.1055/a-1148-3867.
Der volle Inhalt der QuelleHajar Tahiri, Fatima zahra El Fatoiki, Meriem Regragui, Fouzia. Hali, and Soumiya .Chiheb. "A rare occurrence of Hodgkin lymphoma in a Xeroderma pigmentosum patient: A case report and literature review." World Journal of Advanced Research and Reviews 22, no. 1 (2024): 1484–86. http://dx.doi.org/10.30574/wjarr.2024.22.1.1179.
Der volle Inhalt der QuelleHajar, Tahiri, zahra El Fatoiki Fatima, Regragui Meriem, Hali Fouzia., and .Chiheb Soumiya. "A rare occurrence of Hodgkin lymphoma in a Xeroderma pigmentosum patient: A case report and literature review." World Journal of Advanced Research and Reviews 22, no. 1 (2024): 1484–86. https://doi.org/10.5281/zenodo.14225598.
Der volle Inhalt der QuelleAlakshar, Asmaa, Abdul Rahman Mohammed Saleh, and Mehmet Omer Gorduysus. "Debris and Smear Layer Removal from Oval Root Canals Comparing XP-Endo Finisher, EndoActivator, and Manual Irrigation: A SEM Evaluation." European Journal of Dentistry 14, no. 04 (2020): 626–33. http://dx.doi.org/10.1055/s-0040-1714762.
Der volle Inhalt der QuelleRothkopf, Michael. "An Algorithmic Approach for Lipid Metabolism and Management of Patients with Xanthelasma Palpebrarum (XP)." Current Developments in Nutrition 4, Supplement_2 (2020): 1140. http://dx.doi.org/10.1093/cdn/nzaa055_025.
Der volle Inhalt der QuelleSugimoto, Naotoshi, Tetsuhiro Yoshinami, Sachiko Yamamoto, Toshinari Yagi, and Fumio Imamura. "Does capecitabine plus cisplatin (XP) give advanced or recurrent gastric cancer (AGC) patients higher early tumor shrinkage (ETS) rate than S1 plus cisplatin (SP) with safety?" Journal of Clinical Oncology 33, no. 3_suppl (2015): 172. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.172.
Der volle Inhalt der QuelleTakeno, Atsushi, Youichi Makari, Shunji Endo, et al. "Randomized, open-label, phase II study comparing five-weekly S-1 plus cisplatin (SP) with tri-weekly capecitabine plus cisplatin (XP) in chemotherapy-naïve patients with HER2 negative advanced gastric cancer (AGC): OGSG 1105 HERBIS-4A trial." Journal of Clinical Oncology 36, no. 4_suppl (2018): 102. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.102.
Der volle Inhalt der QuelleBahrudin, Ida Aryanie, Rafizah Mohd Hanifa, Mohd Ezree Abdullah, and Muhammad Firdaus Kamarudin. "Adapting eXtreme Programming Approach in Developing Electronic Document Online System (eDoc)." Applied Mechanics and Materials 321-324 (June 2013): 2938–41. http://dx.doi.org/10.4028/www.scientific.net/amm.321-324.2938.
Der volle Inhalt der Quelle